JPWO2021173193A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021173193A5 JPWO2021173193A5 JP2022545967A JP2022545967A JPWO2021173193A5 JP WO2021173193 A5 JPWO2021173193 A5 JP WO2021173193A5 JP 2022545967 A JP2022545967 A JP 2022545967A JP 2022545967 A JP2022545967 A JP 2022545967A JP WO2021173193 A5 JPWO2021173193 A5 JP WO2021173193A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- brain
- antigen
- protein
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025190141A JP2026041745A (ja) | 2020-02-24 | 2025-11-11 | 細胞ベースの治療を脳にホーミング、ブロック及び送達するための脳特異的抗原の使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062980885P | 2020-02-24 | 2020-02-24 | |
| US62/980,885 | 2020-02-24 | ||
| PCT/US2020/059368 WO2021173193A1 (en) | 2020-02-24 | 2020-11-06 | Use of brain-specific antigens to home, block and deliver cell-based treatments to the brain |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025190141A Division JP2026041745A (ja) | 2020-02-24 | 2025-11-11 | 細胞ベースの治療を脳にホーミング、ブロック及び送達するための脳特異的抗原の使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023515322A JP2023515322A (ja) | 2023-04-13 |
| JP2023515322A5 JP2023515322A5 (https=) | 2023-11-10 |
| JPWO2021173193A5 true JPWO2021173193A5 (https=) | 2023-11-10 |
| JP7777872B2 JP7777872B2 (ja) | 2025-12-01 |
Family
ID=77492116
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022545967A Active JP7777872B2 (ja) | 2020-02-24 | 2020-11-06 | 細胞ベースの治療を脳にホーミング、ブロック及び送達するための脳特異的抗原の使用 |
| JP2025190141A Pending JP2026041745A (ja) | 2020-02-24 | 2025-11-11 | 細胞ベースの治療を脳にホーミング、ブロック及び送達するための脳特異的抗原の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025190141A Pending JP2026041745A (ja) | 2020-02-24 | 2025-11-11 | 細胞ベースの治療を脳にホーミング、ブロック及び送達するための脳特異的抗原の使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230055337A1 (https=) |
| EP (1) | EP4110354A4 (https=) |
| JP (2) | JP7777872B2 (https=) |
| CN (1) | CN115151268A (https=) |
| AU (1) | AU2020431140A1 (https=) |
| CA (1) | CA3170412A1 (https=) |
| WO (1) | WO2021173193A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024121414A1 (en) * | 2022-12-08 | 2024-06-13 | Université De Genève | Chimeric antigen receptor |
| WO2025054259A1 (en) * | 2023-09-08 | 2025-03-13 | The Regents Of The University Of California | Guiding development using self-assembling cells |
| CN119306836B (zh) * | 2024-10-14 | 2025-07-11 | 中国人民解放军陆军军医大学第一附属医院 | 抗ptprz1嵌合抗原受体巨噬细胞在肺癌治疗中的应用 |
| CN119286939B (zh) * | 2024-11-15 | 2025-05-02 | 广东君厚生物医药有限公司 | PSR.Syn.CD19.BCMA CAR-T细胞的制备方法及其细胞和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0813621A2 (pt) | 2007-07-27 | 2017-05-09 | Immatics Biotechnologies Gmbh | imunoterapia contra tumores neuronais e cerebrais |
| PL2172211T3 (pl) | 2008-10-01 | 2015-05-29 | Immatics Biotechnologies Gmbh | Kompozycja związanych z guzem peptydów i związana z tym szczepionka przeciwrakowa do leczenia glejaka (GBM) i innych rodzajów raka |
| AU2011323784A1 (en) * | 2010-10-25 | 2013-05-30 | Regents Of The University Of Minnesota | Therapeutic composition for treatment of glioblastoma |
| US20170107578A1 (en) | 2014-03-21 | 2017-04-20 | The Translational Genomics Research Institute | Compositions, methods and kits for characterizing and screening for small cell ovarian carcinoma |
| WO2016138034A1 (en) | 2015-02-24 | 2016-09-01 | The Regents Of The University Of California | Binding-triggered transcriptional switches and methods of use thereof |
| WO2017193059A1 (en) * | 2016-05-06 | 2017-11-09 | The Regents Of The University Of California | Systems and methods for targeting cancer cells |
| EP3560955A4 (en) | 2016-12-26 | 2020-12-23 | Kyowa Kirin Co., Ltd. | ANTIBODIES CAPABLE OF BINDING TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN |
| KR20200071740A (ko) * | 2017-09-28 | 2020-06-19 | 임팩트-바이오 리미티드. | 저해성 키메라 항원 수용체 (icar)를 제조하기 위한 보편적 플랫폼 |
| CA3095757A1 (en) * | 2018-04-06 | 2019-10-10 | The Regents Of The University Of California | Methods of treating glioblastomas |
-
2020
- 2020-11-06 CA CA3170412A patent/CA3170412A1/en active Pending
- 2020-11-06 CN CN202080097603.1A patent/CN115151268A/zh active Pending
- 2020-11-06 JP JP2022545967A patent/JP7777872B2/ja active Active
- 2020-11-06 EP EP20921774.4A patent/EP4110354A4/en active Pending
- 2020-11-06 US US17/792,385 patent/US20230055337A1/en active Pending
- 2020-11-06 AU AU2020431140A patent/AU2020431140A1/en active Pending
- 2020-11-06 WO PCT/US2020/059368 patent/WO2021173193A1/en not_active Ceased
-
2025
- 2025-11-11 JP JP2025190141A patent/JP2026041745A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2821080C (en) | Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer | |
| Narang et al. | Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury, drive secondary injury by activating complement | |
| AU701302B2 (en) | Improvements in or relating to peptide delivery | |
| PH12022550230A1 (en) | Antigen binding proteins specifically binding mage-a | |
| Lin et al. | Keratin 17 in psoriasis: Current understanding and future perspectives | |
| JPWO2020014366A5 (https=) | ||
| MY205262A (en) | Novel t cell receptors and immune therapy using the same | |
| JP2010516290A5 (https=) | ||
| JP2025072445A (ja) | 標的治療免疫調節のためのＭＨＣクラスＩｂ分子及びペプチドの組合せ | |
| CN104039833A (zh) | 针对hpv的疫苗 | |
| MX2023012902A (es) | Proteinas de union a antigenos que se unen especificamente a prame. | |
| DE60141409D1 (de) | Homologe des nogo rezeptors | |
| Aurisicchio et al. | Novel anti‐ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors | |
| JPWO2021173193A5 (https=) | ||
| WO2019089813A1 (en) | Nk-92 cells to stimulate anti-cancer vaccine | |
| JP7428404B2 (ja) | Ｇｓｘ１を使用した脊髄損傷（ｓｃｉ）および脳損傷の処置 | |
| KR102033215B1 (ko) | 건선 유발 동물 모델 및 이의 용도 | |
| Alyaqoub et al. | In vivo synthesis of cyclic-di-GMP using a recombinant adenovirus preferentially improves adaptive immune responses against extracellular antigens | |
| Kim et al. | 022 Distinct transcriptome signature of skin-resident memory T cells and migratory memory T cells in atopic dermatitis | |
| Bak et al. | Calreticulin requires an ancillary adjuvant for the induction of efficient cytotoxic T cell responses | |
| US20230038878A1 (en) | Multispecific nanobodies chimeric antigen receptor and t-cell engager, nucleic acid, expressing cell thereof, pharmaceutical composition for treating cancer, and method for inhibiting proliferation of tumor cell | |
| RU2333918C2 (ru) | ее3-СЕМЕЙСТВО БЕЛКОВ И СООТВЕТСТВУЮЩИЕ ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ | |
| WO2022150379A1 (en) | Nk cell engager molecules and methods of use | |
| Kang et al. | Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide | |
| WO2024089258A1 (en) | Albumin conjugated to cpg oligodeoxynucleotides as super-boosters of immune response |